logo

Slide Shows

Share
Events

Biotech Stocks Facing FDA Decision In June 2022 As another month comes to a close, it’s time to take a look back at some of the healthcare sector news that made headlines in May and look ahead to what’s in store on the regulatory front in June.

Biotech Stocks Facing FDA Decision In March 2022 As another month comes to an end, it’s time to take a look back at some of the regulatory news that made headlines in February and look ahead to what the month of March has in store.

Biotech Stocks Facing FDA Decision In February 2022 As we head into February, it's time to take a look back at some of the regulatory news that made headlines in January.

Biotech Stocks Facing FDA Decision In January 2022 As another month comes to an end, we take a look back at some of the regulatory news that dominated the headlines and look ahead to what’s in store for January.

Biotech Stocks Facing FDA Decision In December 2021 Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa earlier this month, Omicron cases have now been reported in at least 15 countries.

Biotech Stocks Facing FDA Decision In November 2021 Let's take a look at the biotech stocks facing FDA decision in November.

Biotech Stocks Facing FDA Decision In October 2021 The FDA has approved 39 novel drugs so far this year compared to 40 during the same period last year. A total of 53 novel drugs were approved in 2020. Let’s take a look at the biotech stocks facing FDA decision in October.

Biotech Stocks Facing FDA Decision In September 2021 As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.